三钙Phosphate (Feed Grade), CAS# 7758-87-4, is a calcium salt of phosphoric acid manufactured through chemical synthesis, available as WHITE POWDER. Tricalcium Phosphate (Feed Grade) is widely used as nutrition supplements and anticaking agent. It is widely accepted as safe feed additive in many countries with E number E341.
No significant side effects reported.
As Tricalcium Phosphate (Feed Grade) Side Effects is widely known as safe, there is no limit on dosage of intake. However, we still recommend consumers to consult professionals before using large quantity of Tricalcium Phosphate (Feed Grade) Side Effects for long period.
Special groups refer to newborns, children, pregnant and any other applicable vulnerable groups.
There is no evidence that Tricalcium Phosphate (Feed Grade) Side Effects could have any negative effects on these vulnerable groups. It should be safe to use Tricalcium Phosphate (Feed Grade) Side Effects in food for newborns and pregnant. However, we still recommend consumers to consult professionals before using large quantity of Tricalcium Phosphate (Feed Grade) Side Effects for long period in food for newborns or pregnant.
Generally recognized as safe(GRAS) is a FDA designation that a specific substance or ingredient is generally considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food additive tolerance requirements. Tricalcium Phosphate (Feed Grade) Side Effects is perfectly safe for using as food additives.
No health issues about Tricalcium Phosphate (Feed Grade) Side Effects reported up to now.
1. Efficacy of interspinous process lumbar fusion with recombinant human bone morphogenetic protein-2 delivered with a synthetic polymer and β-tricalcium phosphate in a rabbit model.[Eur Spine J. 2012 Jul]
Author: Matsumoto T, Toyoda H, Dohzono S, Yasuda H, Wakitani S, Nakamura H, Takaoka K.
2. Preclinical Toxicology Studies of Recombinant Human Platelet-Derived Growth Factor-BB Either Alone or in Combination with Beta-Tricalcium Phosphate and Type I Collagen.[J Tissue Eng. 2011 Jan 10]
Author: Young CS, Bradica G, Hart CE, Karunanidhi A, Street RM, Schutte L, Hollinger JO.
3. Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects.[J Periodontol。2011年2月)
Author: Jayakumar A, Rajababu P, Rohini S, Butchibabu K, Naveen A, Reddy PK, Vidyasagar S, Satyanarayana D, Pavan Kumar S.
4. A prospective, randomized pilot study on the safety and efficacy of recombinant human growth and differentiation factor-5 coated onto β-tricalcium phosphate for sinus lift augmentation.[Clin Oral Implants Res. 2010 Nov]
Author: Koch FP, Becker J, Terheyden H, Capsius B, Wagner W.
